The International Journal of STD & AIDS provides a clinically oriented forum for investigating and treating sexually transmissible infections, HIV and AIDS. Publishing original research and practical papers, the journal contains in-depth review articles, short papers, case reports, audit reports, CPD papers and a lively correspondence column.
This peer-reviewed journal provides a clinically oriented forum for investigating and treating sexually transmissible infections, HIV and AIDS. Contributors from around the world promote activities aimed at research, prevention and control of these infections. The journal contains in-depth editorial reviews, original articles and research, short papers, case reports, audit reports and CPD papers. There is also a lively correspondence column, a book review section, and news from the genitourinary medicine associations.
Sign up for the latest table of content alerts.
|Michael Rayment||Chelsea and Westminster Hospital, UK|
|W W Dinsmore||NHS Consultant, UK|
|I H Ahmed||Nottingham City Hospital, UK|
|S Barton||Chelsea and Westminster Hospital NHS Foundation Trust, UK|
|J S Bingham||Guy's and St Thomas' Hospitals, UK|
|C Bunker||University College London Hospitals, UK|
|R Chan||National Skin Centre, Singapore|
|Xiang-Sheng Chen||National Center for STD Control, China|
|J Clarke||Leeds General Infirmary, UK|
|R Coker||LSHTM, Department of Global Health and Development, Rajavithi Hospital, Thailand|
|P V Coyle||Belfast Health and Social Care Trust, UK|
|A de Ruiter||Guy's & St. Thomas' Hospital, UK|
|W W Dinsmore||Royal Victoria Hospital, UK|
|M Domeika||Uppsala University, Sweden|
|B Donovan||Sydney Hospital, Australia|
|M Fisher||Brighton and Sussex University Hospitals, UK|
|L Foley||SOLENT NHS TRUST, UK|
|D Freedman||GenitoUrinary Clinic, Ireland|
|B Gazzard||Chelsea and Westminster Hospital NHS Foundation Trust, UK|
|J R W Harris||St Marys Hospital, UK|
|K K Holmes||Harborview Medical Centre, USA|
|J Jensen||Statens Serum Institut, Denmark|
|M Johnson||Royal Free Hospital, UK|
|P Kell||Castle Circus Health Centre, UK|
|L Khotenashvili||WHO Regional Office for Europe, Denmark|
|G Kinghorn||Sheffield Teaching Hospitals NHS Foundation Trust, UK|
|P K Kohl||Vivantes Klinikum Neukölln, Germany|
|R K W Lau||St. George's Hospital, UK|
|C D Llewellyn||Brighton & Sussex Medical School, UK|
|G A Luzzi||Buckinghamshire Hospitals NHS Trust, UK|
|J K Maniar||Jaslok Hospital & Research Center, India|
|R D Maw||Royal Victoria Hospital, UK|
|A McMillan||Formerly, Department of Genitourinary Medicine, NHS Lothian, UK|
|A Meheus||University of Antwerp, Belgium|
|E Morgan||Former Army Staff College, UK|
|F Mulcahy||St. James's Hospital, Ireland|
|R Nandwani||The Sandyford Initiative, UK|
|M Nelson||Chelsea and Westminster Hospital Foundation Trust, UK|
|C P O'Mahony||Countess of Chester NHS Foundation Trust, UK|
|J Paavonen||University of Helsinki, Finland|
|A Palfreeman||Leicester royal infirmary, UK|
|R Patel||Royal South Hants Hospital, UK|
|B S Peters||St. Thomas’ Hospital, UK|
|D Pillay||Royal Free and University College, UK|
|J Potterat||Consultant, STD/HIV epidemiology & control, USA|
|T C Quinn||John Hopkins University, USA|
|K W Radcliffe||Whittall Street Clinic, UK|
|A Robinson||Mortimer Market Centre, UK|
|K E Rogstad||Royal Hallamshire Hospital, UK|
|J Ross||Whittall Street Clinic, UK|
|C Sabin||Royal Free Hospital Sch of Medicine, UK|
|E Sandström||Karolinska Insitutet, Sweden|
|J Sherrard||Oxford Radcliffe Trust, UK|
|A Stary||University of Vienna, Austria|
|N Steedman||Countess of Chester Foundation Trust, UK|
|D Taylor-Robinson||Imperial College London, UK|
|J C Thomas||Pacific University, USA|
|A Ustianowski||Monsall Infectious Diseases Unit, UK|
|M A Waugh||Leeds Teaching Hospitals NHS Trust, UK|
|J N Weber||Imperial College London, UK|
|J White||Guy's and St Thomas' NHS Foundation Trust, UK|
|O E Williams||Wrexham Maelor Hospital, UK|
|J D Wilson||Leeds General Infirmary, UK|
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/ijsa to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of International Journal of STD & AIDS will be reviewed.
The journal adopts the UNAIDS terminology guidelines, all authors need to ensure their submissions uses the preferred terminology as described in the below: https://www.unaids.org/sites/default/files/media_asset/2015_terminology_guidelines_en.pdf
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that International Journal of STD & AIDS may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.
- What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
- Editorial policies
2.1 Peer review policy
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
2.9 Research Data
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open access and author archiving
- Preparing your manuscript
4.2 Artwork, figures and other graphics
4.3 Supplemental material
4.4 Reference style
4.5 English language editing services
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
- Further information
Before submitting your manuscript to International Journal of STD & AIDS, please ensure you have read the Aims & Scope
When assessing the length of your contribution, allow 250 words for each table, figure or group of eight references, since all of these will contribute to its total length.
Suggestions for review articles are welcomed by the Editors and the subject matter should be outlined to the Editors, if possible before writing the article. Maximum length: 3500 words, with up to five tables or illustrations.
Original Research Articles
Original research articles are expected to contribute to the advancement of knowledge in the field of STD and AIDS. Maximum length: 3000 words, with up to five tables or illustrations. Shorter manuscripts of around 1500-2000 words are often as impactful, so please consider 3000 words as a maximum, not an expectation.
All original research articles need to have a structured abstract with the following headings:
Max word count (excluding headers): 250 words
Quality Improvement Articles
These articles should be prepared in a narrative style and comprise a short summary, introduction, methods, results and discussion. Suitable topics include service developments, quality improvement projects, service evaluations, and audit reports (where the audit cycle has been completed). Maximum length 1500 words with 1–2 tables or illustrations.
These should be prepared in a narrative style and comprise a summary; a short introduction stating the reasons for reporting the case; the case report including history, investigations and treatment; and a discussion referring to the relevant literature. Case series are preferable to single case reports. Maximum length 800 words with 1–2 tables or illustrations.
Letters to the Editor
These should relate to articles published recently in the journal. Letters containing novel data will be peer-reviewed. Letters are usually less than 500 words.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
1.3.1 Make your article discoverable
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online
All papers will be reviewed by independent referees, and authors may be requested to amend their contribution. The final decision about acceptance or rejection remains with the Editors. Papers on which the Editors are co-authors are handled by another member of the Editorial Board and are usually sent to at least two independent referees.
The covering letter is important. To help the Editors in their preliminary evaluation, please indicate why you think the paper suitable for publication. If your paper should be considered for fast-track publication, please explain why.
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
- Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
International Journal of STD & AIDS requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of International Journal of STD & AIDS to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.
International Journal of STD & AIDS conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- share your research data in a relevant public data repository
- include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
- cite this data in your research
International Journal of STD & AIDS requests all authors submitting any primary data used in their research articles alongside their article submissions to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor may consider limited embargoes on proprietary data. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact the editorial office at IJSAeditorial@sagepub.co.uk
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
International Journal of STD & AIDS and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway
International Journal of STD & AIDS offers optional open access publishing via the SAGE Choice programme. For more information on Open Access publishing options at SAGE please visit SAGE Open Access. For information on funding body compliance, and depositing your article in repositories, please visit SAGE’s Author Archiving and Re-Use Guidelines and Publishing Policies.
The preferred format for your manuscript is Word. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
International Journal of STD & AIDS is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/ijsa to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID iD to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your OCRID iD will become part of your accepted publication's metadata, making your work attributable to you and only you. Your ORCID iD is published wiht your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
6.3 Access to your published article
SAGE provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of STD & AIDS editorial office as follows: